Login Logout My Account

The Cheap Investor
Making Wise Investments Since 2010
The Cheap InvestorThe Cheap Investor
  • Home
  • Track Record
  • Contact
  • Subscribe
  • Articles
  • Home
  • Track Record
  • Contact
  • Subscribe
  • Articles

Category Archives: Daily Chart

Chart of Day: Gold Challenging Two Year High

Daily Chart, EmailBy Bill MathewsJuly 7, 2016Leave a comment

Gold prices rocketed to their highest point in two years, as investors continue to buy into the safe-haven on low/negative interest rates and lingering global economic concerns. Also fueling gold were comments from New York Federal Reserve President William Dudley who noted the bank would be patient on raising rates on the heels of low…

Chart of Day: Markets Prove to be Resilient

Daily Chart, EmailBy Bill MathewsJuly 5, 2016Leave a comment

Over the last several days, global markets buckled under the strain of increased volatility, and uncertainty.  It was a train wreck of emotional trading. Worldwide markets lost $3 trillion in two days.  The Nikkei lost 1,280 points – the biggest drop in 16 years.  The Dow Jones Industrial Average lost more than 800 points. European…

Chart of Day: Gold Prices Extend Brexit Surge

Daily Chart, EmailBy Bill MathewsJune 28, 2016Leave a comment

Over the last two trading sessions, we’ve seen the global community lose more than $2 trillion of value over the UK vote to leave the European Union.  The news set off a firestorm of fear.  The Dow Jones Industrial Average plummeted 800 points.  The British pound fell to a 30-year low.  Gold surged as expected. …

Chart of Day: Exact Sciences (EXAS) Begins to Slip

Daily Chart, EmailBy Bill MathewsJune 23, 2016Leave a comment

Just the other day, we spoke about Exact Sciences (EXAS), and the reasons for which the stock moved aggressively higher.  While we made no recommendation to buy the stock at such an elevated price, we were careful to point out that it was another example of Wall Street hyping a stock to unrealistic prices because…

Chart of Day: “The Crash will Make All of you Poorer…”

Daily Chart, EmailBy Bill MathewsJune 21, 2016Leave a comment

In September 1992, George Soros “broke the bank of England,” and raked in more than a billion dollars in a single day.  All he did was short the pound. Nowadays, he’s warning that a UK exit from the EU could unleash a similar drop, perhaps by 15% to 20%.  “The Brexit crash will make all…

Chart of Day: Pain Therapeutics (PTIE) Picks up Steam on Teva Findings

Daily Chart, EmailBy Bill MathewsJune 16, 2016Leave a comment

In late 2014, shares of Pain Therapeutics plunged after Pfizer ended an agreement to help it develop and market the Remoxy pain drug along with Durect Corporation. The stock was left for dead, ignored. But things are rapidly improving.  So much so, the stock rocketed from our recommended entry price of $1.83 in the July…

Chart of Day: Electromed (ELMD) Returns 188% Gain

Daily Chart, EmailBy Bill MathewsJune 14, 2016Leave a comment

It may not be one of the most exciting stocks on the market. But it’s a moneymaker.  The stock – Eletromed – develops, designs, manufacturers, and markets airway products, such as its SmartVest airway system to patients suffering from cystic fibrosis, bronchiectasis, pneumonia, and neuromuscular disorders, and to patients with post-surgical complications or is considered…

Chart of Day: ACADIA (ACAD) Could Fetch $60

Daily Chart, EmailBy Bill MathewsJune 7, 2016Leave a comment

The buyout rumors are heating up. After the FDA granted approval for ACAD’s Parkinson’s disease Psychosis (PDP) treatment, the list of potential acquirers is getting longer. Not only is Pfizer, Biotgen, and Teva reportedly interested in the company, but now reports are surfacing that AstraZeneca may be a potential bidder, too.  Sources say ACADIA may…

Chart of Day: Galena Biopharma (GALE) up 80%

Daily Chart, EmailBy Bill MathewsJune 2, 2016Leave a comment

Over the last year, The Cheap Investor made a recommendation to buy Galena Biopharma (GALE) at just $1.33 in June 2015, and again at $1.67 in August 2015.  As of today, the stock last traded at $2.29 for potential gains of 37% and 80%. The stock is tracking even higher after the FDA designated its…

Chart of Day: Celator Pharmaceuticals (CPXX) Returns 911%

Daily Chart, EmailBy Bill MathewsMay 31, 2016Leave a comment

In the November 2015 issue of The Cheap Investor, we made a recommendation to pick up shares of CPXX at just $1.75 a share.  Just months later, the stock skyrocketed to a high of $17.69 for potential gains of 911% on news of successful Phase III clinical results for VYXEOS for patients with high risk…

Chart of 2016: The Ultimate Disruptive Cancer Treatment

Daily Chart, EmailBy Bill MathewsMay 26, 2016Leave a comment

As we near the June 2016 ASCO event in Chicago, Illinois, immunotherapy has again t taken center stage… especially as the FDA approves a treatment to help battle an advanced form of bladder cancer, know as urotherial carcinoma. Developed by Genentech, the treatment works by strengthening the body’s own immune, training it to attack bladder…

Chart of Day: Could ACADIA Pharmaceuticals (ACAD) see a Buyout Offer?

Daily Chart, EmailBy Bill MathewsMay 24, 2016Leave a comment

The buyout rumors are swirling.  Pfizer (FPE), Biogen (BIIB) and Teva Pharmaceuticals (TEVA) are all reportedly interested in Parkinson’s disease Psychosis (PDP) drug stock, ACADIA Pharmaceuticals (ACAD).  Analysts believe ACAD could see at least a $6 billion buyout offer after the FDA approved its PDP drug that could help up to 40% of all Parkinson’s…

12345…
678
9
DISCLAIMER: The Cheap Investor, together with its affiliates, is a publisher of financial news and opinions. Past performance is not a guarantee of future results. You alone are responsible for your own investment decisions. You should independently verify all information contained within newsletters, alerts and profiles or on our website(s) and consider obtaining professional advice before making any investment decision. Past performance is no guarantee of future success and you should not assume that the securities of companies profiled in current or future newsletters, alerts and profiles or on our website(s) will perform better than or even equal to the performance of the securities of companies profiled or mentioned in prior newsletters, alerts and profiles or on our website(s). All stock investments carry some degree of risk. By investing in any of the stocks of the companies profiled or mentioned in the newsletters, alerts and profiles or on our website(s) you can and may lose some or all of your investment. Do not invest in any stock if you are not prepared to lose your entire investment. As a condition to accessing The Cheap Investor materials and websites, you agree to our Full Disclaimer, Terms and Conditions of Use and Privacy Policy, including without limitation all disclaimers of warranties and limitations on liability contained therein. The Cheap Investor and its affiliates, principals, employees, partners, directors and agents may hold positions in the securities that are discussed in our newsletters or on our website. Please be sure to fully read all disclaimers and disclosures contained in newsletters, alerts and profiles or on our website(s).
Copyright 1981-2018 © Inspiren, LLC
Go to Top